Several studies focusing on brain irradiation are in progress. Reflecting updates of relevant outcomes in palliative treatment of patients suffering from brain metastases, the primary objective of these studies is the evaluation of neurocognitive function and quality of life. Improvements of technology in radiation oncology allows us to spare the hippocampal region while appropriately irradiating other parts of brain tissue. Irradiation of the hippocampus region is likely to lead to manifestations of adverse events with a subsequent impact on patient's quality of life, which is in fact an improper approach in palliative medicine. Ongoing studies evaluate results of hippocampus avoiding radiotherapy compared to standard whole brain radiotherapy. Incorporation of neurocognitive function assessment may result in the confirmation of superiority of sparing the region of hippocampus and thus change current style of providing brain irradiation.

Department of Radiation Oncology Faculty of Medicine Masaryk University and Masaryk Memorial Cancer Institute Žlutý kopec 7 Brno 656 53 Czech Republic

International Clinical Research Center Department of Neurosurgery St Anne's University Hospital Brno Brno Czech Republic

See more in PubMed

Wen P.Y., Black P.M., Loeffler J.S. Metastatic brain cancer. In: DeVita V., Hellman S., Rosenberg S.A., editors. Cancer: principles and practice of oncology. Williams & Wilkins/Lippincott; Philadelphia, PA: 2001. pp. 2655–2670.

Seute T., Leffers P., ten Velde G.P., Twijnstra A. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI) Cancer. 2008;112(8):1827–1834. PubMed

Marc D., Okunieff P., Milano M.T. Brain metastases. In: Gunderson L.L., Tepper J.E., editors. Clinical radiation oncology. Elsevier Saunders; Philadelphia: 2012. pp. 421–438.

National Comprehensive Cancer Network (NCCN) 2012. NCCN Clinical Practice Guidelines in Oncology. Palliative care Version 2.2012.http://www.nccn.org/professionals/physician_gls/pdf/palliative.pdf Online at. Version 2 (last accessed 09.09.12) PubMed

Meyers C.S., Rock E.P., Fine H.A. Refining endpoints in brain tumor clinical trials. J Neurooncol. 2012;108(2):227–230. PubMed

Linskey M.E., Andrews D.A., Asher A.L. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systemic review and evidence-based clinical practice guideline. J. Neurooncol. 2010;96:45–68. PubMed PMC

Saminathan S., Chandraraj V., Sridhar C.H., Manickam R. Comparison of individual and composite field analysis using array detector for intensity modulated radiotherapy dose verification. Rep Pract Oncol Radiother. 2012;17(3):157–162. PubMed PMC

Gaspar L., Scott C., Rotman M. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–751. PubMed

Sperduto P.W., Berkey B., Gaspar L.E. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70:510–514. PubMed

Patchell R.A., Tibbs P.A., Regine W.F. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280:1485–1489. PubMed

Aoyama H., Shirato H., Tago M. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295:2483–2491. PubMed

Chang E.L., Wefel J.S., Hess K.R. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10:1037–1044. PubMed

Kocher M., Soffietti R., Abacioglu U. Adjuvant whole- brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29(2):134–141. PubMed PMC

Abe E., Aoyama H. The role of whole brain radiation therapy for the management of brain metastases in the era of stereotactic radiosurgery. Curr Oncol Rep. 2012 Feb;14(1):79–84. PubMed

Aoyama H. Radiation therapy for brain metastases in breast cancer patients. Breast Cancer. 2011;18(4):244–251. PubMed

Fernandes G, Pocinho R, Travancinha C, Netto E, Roldao M. Quality of life and radiotherapy in brain metastasis patients. Rep Pract Oncol Radiother. Article available online at http://www.sciencedirect.com/science/article/pii/S1507136712001290 (05.09.12), http://dx.doi.org/10.1016/j.rpor.2012.08.003. PubMed DOI PMC

Aoyama H., Tago M., Kato N. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007;68:1388–1395. PubMed

Scoccianti S., Ricardi U. Treatment of brain metastases: review of phase III randomized controlled trials. Radiother Oncol. 2012;102:168–179. PubMed

Gondi V., Tomé W.a, Mehta M.P. Why avoid the hippocampus? A comprehensive review. Radiother Oncol. 2010;97(December (3)):370–376. PubMed PMC

Li J., Bentzen S.M., Renschler M. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol. 2007;25:1260–1266. PubMed

Delattre J.Y., Krol G., Thaler H.T. Distribution of brain metastases. Arch Neurol. 1988;45:741–744. PubMed

Barret A., Dobbs J., Morris S., Roques T. Cerebral metastases. In: Barret A., Dobbs J., Morris S., Roques T., editors. Practical radiotherapy planning. Hodder Arnold; London: 2009. pp. 227–230.

Abayomi O.K. Pathogenesis of irradiation-induced cognitive dysfunction. Acta Oncol. 1996;35:659–663. PubMed

Monje M.L., Mizumatsu S., Fike J.R. Irradiation induces neural precursor-cell dysfunction. Nat Med. 2002;8:955–962. PubMed

Mizumatsu S., Monje M.L., Morhardt D.R. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res. 2003;63:4021–4027. PubMed

Gondi V., Tome W.A., Marsh J. Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol. 2010;95(3):327–331. PubMed PMC

Palacova M., Svoboda M., Fabian P. Tumor phenotype and characteristics of metastatic brain involment in breast cancer patients: potential clinical consequences, ASCO annual meeting proceedings 2009. J Clin Oncol. 2009;27(15):1026. PubMed

Scoccianti S., Detti B., Cipressi S. Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy. J Neurooncol. 2012;108:291–308. PubMed

Monje M.L., Palmer T. Radiation injury and neurogenesis. Curr Opin Neurol. 2003;16:129–134. PubMed

Eriksson P.S., Perfilieva E., Bjork-Eriksson T. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4:1313–1317. PubMed

Gould E., Beylin A., Tanapat P. Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci. 1999;2:260–265. PubMed

Marsh J.C., Gielda B.T., Herskovic A.M., Abrams R.A. Cognitive sparing during the administration of whole brain radiotherapy and prophylactic cranial irradiation: current concepts and approaches. J Oncol. 2010:198–208. PubMed PMC

van Kesteren Z., Belderbos J., van Herk M. A practical technique to avoid the hippocampus in prophylactic cranial irradiation for lung cancer. Radiother Oncol. 2012;102(February (2)):225–227. PubMed

Mehta MP. A phase II trial of hippocampal avoidance during whole brain radiotherapy for brain metastases. RTOG 0933 study protocol. Available online at http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0933 (last accessed 09.09.12).

Bayer S.A. Changes in the total number of dentate granule cells in juvenile and adult rats: a correlated volumetric and 3H-thymidine autoradiographic study. Exp Brain Res. 1982;46:315–323. PubMed

Collier T.J., Quirk G.J., Routtenberg A. Separable roles of hippocampal granule cells in forgetting and pyramidal cells in remembering spatial information. Brain Res. 1987;409:316–328. PubMed

Jalali R., Mallick I., Dutta D. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2010;77:974–979. PubMed

Gondi V., Tolakanahalli R., Mehta M.P. Hippocampal-sparing whole-brain radiotherapy: a “how-to” technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78:1244–1252. PubMed PMC

Hippocampal proton MR spectroscopy as a novel approach in the assessment of radiation injury and the correlation to neurocognitive function impairment: initial experiences